Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 2.790
-0.010 (-0.36%)
Aug 27, 2026, 9:50 AM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 75.48 million as of August 26, 2026. Its market cap has decreased by -31.63% in one year.
Market Cap
75.48M
Enterprise Value
136.51M
Revenue
42.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.79
ChartMarket Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 75.48M, a decrease of -88.70%. That is a compound annual growth rate of -32.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 75.48M | -14.63% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.60B |
| Thor Medical ASA | 2.49B |
| Nykode Therapeutics AS | 1.49B |
| ArcticZymes Technologies ASA | 1.05B |
| Zelluna ASA | 620.63M |
| Lytix Biopharma ASA | 592.13M |
| Oncoinvent ASA | 377.08M |
| SoftOx Solutions AS | 224.27M |